Retinoblastoma: Genetics and pathology

International Ophthalmology Clinics

Volumn 49, Issue 1, 2009, Pages 155-164

  Poulaki, Vasiliki ^a   Mukai, Shizuo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; GENE DELETION; GENE MUTATION; HUMAN; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW;

GENES, RETINOBLASTOMA; HUMANS; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 59449089659     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181924bc2     Document Type: Review

References (43)

1. Mahoney MC, Burnett WS, Majerovics A, et al. The epidemiology of ophthalmic malignancies in New York State. Ophthalmology. 1990;97:1143-1147.
2. Balmer A, Zografos L, Munier F. Diagnosis and current management of retinoblastoma. Oncogene. 2006;25:5341-5349.
3. Kivela T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol. 1999; 17:1829-1837.
4. MacCarthy A, Draper GJ, Steliarova-Foucher E, et al. Retinoblastoma incidence and survival in European children (1978-1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2092-2102.
5. Abramson DH, Schefler AC. Update on retinoblastoma. Retina. 2004;24:828-848.
6. Orjuela M, Castaneda VP, Ridaura C, et al. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res. 2000;6:4010-1016.
7. Abramson DH, Schefler AC, Dunkel IJ, et al. Neoplasms of the Eye. In: Kufe DW, Pollock RE, Weichselbaum RR, et al, eds. Cancer Medicine. 6th ed. Hamilton, Ont; Lewiston, NY: BC Decker Inc; 2003:1233-1250.
8. McLean IW. Retinoblastoma: pathology and prognosis. In: Albert DM, Polans A, eds. Ocular Oncology. New York: Marcel Dekker: Informa Healthcare; 2003:427-448.
9. Mullaney PB, Karcioglu ZA, al-Mesfer S, et al. Presentation of retinoblastoma as phthisis bulbi. Eye. 1997;11(Pt 3):403-408.
10. Gallie BL, Phillips RA, Ellsworth RM, et al. Significance of retinoma and phthisis bulbi for retinoblastoma. Ophthalmology. 1982;89:1393-1399.
11. Margo C, Hidayat A, Kopelman J, et al. Retinocytoma. A benign variant of retinoblastoma. Arch Ophthalmol. 1983;101:1519-1531.
12. Balmer A, Munier F, Gailloud C. Retinoma. Case studies. Ophthalmic Paediatr Genet. 1991;12:131-137.
13. Godbout R, Dryja TP, Squire J, et al. Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma. Nature. 1983;304:451-453.
14. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986; 323:643-646.
15. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971;68:820-823.
16. Leiderman YI, Kiss S, Mukai S. Molecular genetics of RBI-the retinoblastoma gene. Semin Ophthalmol. 2007;22:247-254.
17. Dryja TP, Mukai S, Petersen R, et al. Parental origin of mutations of the retinoblastoma gene. Nature. 1989;339:556-558.
18. Strahm B, Malkin D. Hereditary cancer predisposition in children: genetic basis and clinical implications. Int J Cancer. 2006;119:2001-2006.
19. Gallie BL, Ellsworth RM, Abramson DH, et al. Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer. 1982;45: 513-521.
20. Eagle RC Jr, Shields JA, Donoso L, et al. Malignant transformation of spontaneously regressed retinoblastoma, retinoma/retinocytoma variant. Ophthalmology. 1989;96: 1389-1395.
21. Dimaras H, Coburn B, Pajovic S, et al. Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma. Mol Carcinog. 2006;45:333-343.
22. Kapic A, Helmbold H, Reimer R, et al. Cooperation between p53 and pl30(Rb2) in induction of cellular senescence. Cell Death Differ. 2006;13:324-334.
23. Corson TW, Gallie BL. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer. 2007;46:617-634.
24. Laurie NA, Donovan SL, Shih CS, et al. Inactivation of the p53 pathway in retinoblastoma. Nature. 2006;444:61-66.
25. Sakai T, Ohtani N, McGee TL, et al. Oncogenic germ-line mutations in Spl and ATF sites in the human retinoblastoma gene. Nature. 1991;353:83-86.
26. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6: 857-866.
27. Calin GA, Croce CM. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene. 2006;25:6202-6210.
28. Huang JC, Babak T, Corson TW, et al. Using expression profiling data to identify human microRNA targets. Nat Methods. 2007;4:1045-1049.
29. Abramson DH, Gombos DS. The topography of bilateral retinoblastoma lesions. Retina. 1996;16:232-239.
30. Sang DN, Albert DM. Retinoblastoma: clinical and histopathologic features. Hum Pathol. 1982;13:133-147.
31. Schwimer CJ, Prayson RA. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry. Ann Diagn Pathol. 2001;5:148-154.
32. Bunt AH, Tso MO. Feulgen-positive deposits in retinoblastoma. Incidence, composition, and ultrastructure. Arch Ophthalmol. 1981;99:144-150.
33. Tajima Y, Munakata S, Ishida Y, et al. Photoreceptor differentiation of retinoblastoma: an electron microscopic study of 29 retinoblastomas. Pathol Int. 1994;44:837-843.
34. Merriam GR Jr. Retinoblastoma; analysis of 17 autopsies. Arch Ophthalmol. 1950;44: 71-108.
35. Carbajal UM. Metastasis in retinoblastoma. Am J Ophthalmol. 1959;48:47-69.
36. Rubin CM, Robison LL, Cameron JD, et al. Intraocular retinoblastoma group V: an analysis of prognostic factors. J Clin Oncol. 1985;3:680-685.
37. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987;94: 371-377.
38. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96:217-222.
39. Messmer EP, Heinrich T, Hopping W, et al. Risk factors for metastases in patients with retinoblastoma. Ophthalmology. 1991;98:136-141.
40. Marback EF, Arias VE, Paranhos A Jr, et al. Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma. Br J Ophthalmol. 2003;87: 1224-1228.
41. Rossler J, Dietrich T, Pavlakovic H, et al. Higher vessel densities in retinoblastoma with local invasive growth and metastasis. Am J Pathol. 2004;164:391-394.
42. Chong EM, Coffee RE, Chintagumpala M, et al. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med. 2006; 130: 1669-1672.
43. Chantada GL, Dunkel IJ, de Davila MT, et al. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? Br J Ophthalmol. 2004;88: 1069-1073.